Table 4 The interactions between TN and PPD-type GS for thrombin inhibitory activity.
1. Ginsenoside-Rb1 | 2. Ginsenoside-Rd | |||||
|---|---|---|---|---|---|---|
Thrombin inhibition (%) at different combination ratios | Thrombin inhibition (%) at different combination ratios | |||||
1/4GS + 1TN | 1/2GS + 1TN | 1GS + 1TN | 1/4GS + 1TN | 1/2GS + 1TN | 1GS + 1TN | |
Dihydrotanshinone I | 44.30 ± 2.01 | 39.47 ± 3.72 | 9.87 ± 2.79 | 38.72 ± 1.92 | 27.61 ± 1.41 | 2.68 ± 2.37 |
Counteraction a | Counteraction | |||||
Tanshinone I | 31.05 ± 8.19 | 30.19 ± 9.19 | 4.83 ± 4.83 | 71.20 ± 0.00 | 5.20 ± 3.39 | 2.20 ± 2.55 |
Counteraction | Counteraction | |||||
Cryptotanshinone | 24.88 ± 0.86 | −10.24 ± 2.41 | −16.75 ± 3.44 | 8.82 ± 2.79 | −5.31 ± 2.55 | −7.65 ± 4.10 |
Reverse b | Reverse | |||||
Tanshinone IIA | 34.02 ± 1.86 | 2.05 ± 0.32 | −9.74 ± 0.48 | 69.17 ± 3.74 | −2.09 ± 3.34 | −4.10 ± 1.18 |
Reverse | Reverse | |||||
